Bioproduction Market Size, Competitors Strategy, Regional Analysis and Industry Growth by Forecast to 2030

The bioproduction market size is projected to grow from US$ 22,337.24 million in 2022 to US$ 63,393.93 million by 2030; the market is estimated to record a CAGR of 13.9% during 2022-2030.

Market Insights and Analyst View :

Automation can deliver many benefits for cell therapy developers, including reduced risk of contamination, improved consistency, and reduced cost of production. Many companies have offered devices to enable automation, such as the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi, which are designed to enable automation in most sequential unit operations for a CAR-T process within a single system. A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. In addition, the evolution of cell therapy, from an academic and clinical setting to mass production and commercialization, is increasing the demand for automation in manufacturing. Increasing research activities in cell therapies have led to a rise in demand for advanced manufacturing solutions.

Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00030322?utm_source=OpenPR&utm_medium=10860

Key Players Analysis :

• Thermo Fisher Scientific Inc
• Merck KGaA
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc
• Lonza Group AG
• bbi-biotech GmbH
• Danaher Corp
• Sartorius AG
• FUJIFILM Irvine Scientific Inc

Report Segmentation and Scope :

The "bioproduction market" is segmented on the basis of product, application, equipment, and end user. The bioproduction market, by product, is subsegmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest market share in 2022; the cell and gene therapies segment is estimated to register the highest CAGR in the market during 2022-2030. Based on application, the bioproduction market is divided into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest market share in 2022 and is predicted to register the highest CAGR during 2022-2030. In terms of equipment, the bioproduction market is segmented into consumables and accessories, downstream equipment, bioreactors, and upstream equipment. The consumables and accessories segment held the largest market share in 2022 and is anticipated to grow at the fastest rate during 2022-2030. The bioproduction market, by end user, is segmented into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest market share in 2022. The contract manufacturing organizations segment is projected to register the highest CAGR in the market during 2022-2030. 

Segmental Analysis :

The bioproduction market, by product, is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest market share in 2022. The cell and gene therapies segment is estimated to register the highest CAGR in the market during 2022-2030. Cell therapy and gene therapy are the overlapping fields in biomedical treatment and research. Both therapies aim to prevent, treat, or potentially cure diseases. Moreover, both therapies can improve the underlying cause of genetic and acquired diseases. Cell therapy intends to treat diseases by restoring or modifying several sets of cells outside the body before being injected into the patient or by using cells to carry a therapy across the body. Gene therapy aims to treat diseases by restoring or introducing new genes into cells-either outside of the body (ex vivo) or inside the body (in vivo). The gene therapies work by adjusting genes in specific types of cells and incorporating them into the body.

Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00030322?utm_source=OpenPR&utm_medium=10860

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Bioproduction Market based on various segments. It also provides market size and forecast with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bioproduction Market by each region is later sub-segmented by respective countries and segments.

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.